Literature DB >> 11469899

A novel model of ischemia in renal tubular cells which closely parallels in vivo injury.

K K Meldrum1, D R Meldrum, K L Hile, A L Burnett, A H Harken.   

Abstract

PURPOSE: Renal ischemia-reperfusion (IR) injury is a devastating clinical problem. While effective animal models have been developed to investigate this condition, they are limited by differential renal cell inflammatory mediator production and heterogeneous cell sensitivity to ischemia. We therefore developed an in vitro model of renal tubular cell ischemia that simulates the cellular injury observed in animal models of renal IR injury.
MATERIALS AND METHODS: Using the established renal tubular cell line, LLC-PK1, simulated ischemia was induced by immersing the cellular monolayer in mineral oil. The effect of simulated ischemia on renal tubular cells was then determined by measuring the time course of TNF-alpha protein expression (ELISA), TNF-alpha mRNA induction (RT-PCR), and renal tubular cell apoptosis (TUNEL).
RESULTS: Maximal TNF-alpha protein expression occurs following 60 min of simulated ischemia and 2 h of substrate replacement (reimmersion in media), and maximal TNF-alpha mRNA induction occurs following 60 min of simulated ischemia. Cellular apoptosis peaks following 60 min of simulated ischemia and 24 h of reperfusion.
CONCLUSION: The time course of TNF-alpha production and apoptosis induction in this model closely parallels the time course for these markers in vivo. This study constitutes the initial demonstration that an in vitro oil immersion model of ischemia simulates the cellular injury (TNF-alpha production and apoptosis) observed in animal models of renal ischemia-reperfusion. This model may be used to study cellular mechanisms of IR in the absence of the systemic confounding variables. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469899     DOI: 10.1006/jsre.2001.6201

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  26 in total

1.  CRRL269.

Authors:  Yang Chen; Gail J Harty; Ye Zheng; Seethalakshmi R Iyer; Shinobu Sugihara; S Jeson Sangaralingham; Tomoko Ichiki; Joseph P Grande; Hon-Chi Lee; Xiaoli Wang; John C Burnett
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

2.  Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.

Authors:  Qi Cao; Yiping Wang; Zhiguo Niu; Chengshi Wang; Ruifeng Wang; Zhiqiang Zhang; Titi Chen; Xin Maggie Wang; Qing Li; Vincent W S Lee; Qingsong Huang; Jing Tan; Minghao Guo; Yuan Min Wang; Guoping Zheng; Di Yu; Stephen I Alexander; Hui Wang; David C H Harris
Journal:  J Am Soc Nephrol       Date:  2018-01-02       Impact factor: 10.121

3.  Ischemic postconditioning inhibits apoptosis of renal cells following reperfusion: a novel in vitro model.

Authors:  Xiaodong Weng; Min Wang; Hui Chen; Zhiyuan Chen; Xiuheng Liu
Journal:  Int Urol Nephrol       Date:  2015-05-05       Impact factor: 2.370

4.  Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury.

Authors:  Aparna Krishnamoorthy; Amrendra Kumar Ajay; Dana Hoffmann; Tae-Min Kim; Victoria Ramirez; Gabriela Campanholle; Norma A Bobadilla; Sushrut S Waikar; Vishal S Vaidya
Journal:  Blood       Date:  2011-06-17       Impact factor: 22.113

5.  Identification of a microRNA signature of renal ischemia reperfusion injury.

Authors:  Jonathan G Godwin; Xupeng Ge; Kristin Stephan; Anke Jurisch; Stefan G Tullius; John Iacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-22       Impact factor: 11.205

6.  Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart.

Authors:  Romain Harmancey; Hernan G Vasquez; Patrick H Guthrie; Heinrich Taegtmeyer
Journal:  FASEB J       Date:  2013-06-27       Impact factor: 5.191

7.  IL-25 Elicits Innate Lymphoid Cells and Multipotent Progenitor Type 2 Cells That Reduce Renal Ischemic/Reperfusion Injury.

Authors:  Qingsong Huang; Zhiguo Niu; Jing Tan; Jun Yang; Yun Liu; Haijun Ma; Vincent W S Lee; Shuming Sun; Xiangfeng Song; Minghao Guo; Yiping Wang; Qi Cao
Journal:  J Am Soc Nephrol       Date:  2015-01-02       Impact factor: 10.121

8.  Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.

Authors:  Jaklien C Leemans; Geurt Stokman; Nike Claessen; Kasper M Rouschop; Gwendoline J D Teske; Carsten J Kirschning; Shizuo Akira; Tom van der Poll; Jan J Weening; Sandrine Florquin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

9.  TLR4 activation mediates kidney ischemia/reperfusion injury.

Authors:  Huiling Wu; Gang Chen; Kate R Wyburn; Jianlin Yin; Patrick Bertolino; Josette M Eris; Stephen I Alexander; Alexandra F Sharland; Steven J Chadban
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Arctigenin alleviates myocardial infarction injury through inhibition of the NFAT5-related inflammatory phenotype of cardiac macrophages/monocytes in mice.

Authors:  Shi-Hao Ni; Shu-Ning Sun; Zheng Zhou; Yue Li; Yu-Sheng Huang; Huan Li; Jia-Jia Wang; Wei Xiao; Shao-Xiang Xian; Zhong-Qi Yang; Ling-Jun Wang; Lu Lu
Journal:  Lab Invest       Date:  2019-12-02       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.